FXN gene therapy (Lacerta Therapeutics)

N/A

Report date: 2025/01/26 17:16:42

Base Information

Drug NameFXN gene therapy (Lacerta Therapeutics)
Drug Alias NamerAAV9-CBA-hFXN (Lacerta Therapeutics)
ClassificationOther
Mechanisms of ActionFrataxin Gene transference
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLacerta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLacerta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFriedreich Ataxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A